Evaluation of the Impact of EHR-Alerts on Clinical Decision Support Pathway Use in Bronchiolitis, and the Impact of Pathway Use on the Prescription of High Flow Nasal Cannula and Other Elements of High Value Care.
NCT06932341 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8000
Last updated 2026-05-29
Summary
The goal of this experimental study is to learn whether different types of Electronic Health Record (EHR) alerts that direct clinicians to reference clinical guidelines embedded in the increase the use of these guidelines and the delivery of evidence-based care in children presenting to the hospital with bronchiolitis. The main questions it aims to answer are:
* Do EHR-alerts increase clinicians' us of evidence-based EHR-integrated Clinical Decision Support (CDS) guidelines for the care of bronchiolitis and
* Is the use of EHR-integrated CDS-guidelines for the care of bronchiolitis associated with deceases in low-value use of High Flow Nasal Cannula (HFNC) and improvement in other aspects of high-value care for this disease
Patients will be randomized on the encounter-level to have the patient's treating providers receive no EHR-alert or one of two types of EHR-alert (non-interruptive or interruptive) reminding the provider that the EHR-integrated CDS guideline is available for the care or bronchiolitis. Researchers will compare the rate of use of EHR-integrated CDS guidelines in patients whose clinicians did not receive any EHR-alerts, to those whose clinicians received a non-interruptive alert and to those whose clinicians received an interruptive Best Practice Advisory (BPA). In addition, the study will evaluate whether the utilization of the EHR-integrated CDS guideline in a given encounter was associated with less low-value HFNC use, and differences in other elements of low-value care for bronchiolitis.
Patients in all groups will continue to receive standard hospital care for bronchiolitis as determined by the patient's treating clinicians.
Conditions
- Bronchiolitis
Interventions
- OTHER
-
Non-interruptive
The non-interruptive EHR alert appears as a visual cue but does not require clinicians to alter workflows. The alert directs clinicians to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.
- OTHER
-
Interruptive
The interruptive EHR alert requires clinicians to interact with the alert to continue the workflow. The alert directs clinicians to reference the EHR-embedded, evidence-based clinical guideline for the care of bronchiolitis.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Benjamin E Bodnar, MD · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-05
- Primary Completion
- 2026-06-14
- Completion
- 2026-07-14
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
NCT03521063 ·Status: UNKNOWN ·Phase: PHASE4
-
The Bronchiolitis in Hospitalized Infants Study
NCT05994183 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation
NCT06842238 ·Status: RECRUITING
-
Impact of Oximetry on Hospitalization in Acute Bronchiolitis
NCT00673946 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Nasal Suction Devices in Children With Bronchiolitis: A Pilot Study
NCT02219334 ·Status: TERMINATED ·Phase: NA
-
The Bronchiolitis Follow-up Intervention Trial
NCT03354325 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis
NCT06053684 ·Status: RECRUITING ·Phase: NA
-
Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia
NCT05534685 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age
NCT07202585 ·Status: COMPLETED
-
Aligning Pulse Oximetry With Guidelines
NCT04178941 ·Status: COMPLETED ·Phase: NA
-
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
NCT05364385 ·Status: UNKNOWN ·Phase: PHASE4
-
Home Oxygen Therapy in Bronchiolitis
NCT01216553 ·Status: UNKNOWN ·Phase: PHASE4
-
Bronchiolitis in Infants Placebo Versus Epinephrine and Dexamethasone Study
NCT03567473 ·Status: COMPLETED ·Phase: PHASE3
-
Parental Assessment of the Quality of Life of Infants With Bronchiolitis Episodes
NCT04135430 ·Status: COMPLETED
-
Impact Of A Health Care Protocol For Patients Suffering Symptoms Of Mild Acute Viral Bronchiolitis On Early Release In The Emergency Department
NCT01091064 ·Status: WITHDRAWN ·Phase: PHASE2
-
Utility of Severity Scales in Clinical Practice in Children Hospitalized Due to Bronchiolitis.
NCT06737159 ·Status: NOT_YET_RECRUITING
-
Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis
NCT02834819 ·Status: TERMINATED ·Phase: NA
-
Weight-based Flow Rates for Children With Bronchiolitis on High-Flow Nasal Cannula: A Pilot Randomized Control Trial
NCT03492307 ·Status: COMPLETED ·Phase: NA
-
Outpatient Pediatric Pulse Oximeters in Africa
NCT05914324 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Atrial and Brain Natriuretic Peptides in Bronchiolitis
NCT00347880 ·Status: COMPLETED
-
Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)
NCT07134387 ·Status: RECRUITING
-
Follow up of Ventilatory Function in Infant After Bronchiolitis During the First Year of Life
NCT00676351 ·Status: COMPLETED ·Phase: NA
-
High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis
NCT03252119 ·Status: TERMINATED ·Phase: NA
-
Hypertonic Saline for Acute Bronchiolitis
NCT01247064 ·Status: COMPLETED ·Phase: PHASE4
-
Physiotherapy for Infants With Bronchiolities
NCT03575091 ·Status: UNKNOWN ·Phase: NA